More than 50 new inhibitors of the oncogenic Stat3 protein were identified through a structure-activity relationship (SAR) study based on the previously identified inhibitor S3I-201 (IC₅₀ =86 μM, K(i) >300 μM). A key structural feature of these inhibitors is a salicylic acid moiety, which, by acting as a phosphotyrosine mimetic, is believed to facilitate binding to the Stat3 SH2 domain. Several of the analogues exhibit higher potency than the lead compound in inhibiting Stat3 DNA binding activity, with an in vitro IC₅₀ range of 18.7-51.9 μM, and disruption of Stat3-pTyr peptide interactions with K(i) values in the 15.5-41 μM range. One agent in particular exhibited potent inhibition of Stat3 phosphorylation in both breast and multiple myeloma tumor cells, suppressed the expression of Stat3 target genes, and induced antitumor effects in tumor cells harboring activated Stat3 protein.
More than 50 new inhibitors of the oncogenic n class="Gene">Stat3 proteinpan> were idenpan>tified through a structure-activity relationpan>ship (SAR) study based onpan> the previously idenpan>tified inpan>hibitor pan> class="Chemical">S3I-201 (IC₅₀ =86 μM, K(i) >300 μM). A key structural feature of these inhibitors is a salicylic acid moiety, which, by acting as a phosphotyrosine mimetic, is believed to facilitate binding to the Stat3 SH2 domain. Several of the analogues exhibit higher potency than the lead compound in inhibiting Stat3 DNA binding activity, with an in vitro IC₅₀ range of 18.7-51.9 μM, and disruption of Stat3-pTyr peptide interactions with K(i) values in the 15.5-41 μM range. One agent in particular exhibited potent inhibition of Stat3 phosphorylation in both breast and multiple myelomatumor cells, suppressed the expression of Stat3 target genes, and induced antitumor effects in tumor cells harboring activated Stat3 protein.
Authors: Pijus K Mandal; Patricia A Heard; Zhiyong Ren; Xiaomin Chen; John S McMurray Journal: Bioorg Med Chem Lett Date: 2006-11-06 Impact factor: 2.823
Authors: Patrick T Gunning; William P Katt; Matthew Glenn; Khandaker Siddiquee; Khandaker Siddique; Joon S Kim; Richard Jove; Saïd M Sebti; James Turkson; Andrew D Hamilton Journal: Bioorg Med Chem Lett Date: 2007-01-27 Impact factor: 2.823
Authors: Sina Haftchenary; H Artee Luchman; Andriana O Jouk; Anthony J Veloso; Brent D G Page; Xin Ran Cheng; Sean S Dawson; Natalie Grinshtein; Vijay M Shahani; Kagan Kerman; David R Kaplan; Carly Griffin; Ahmed M Aman; Rima Al-Awar; Samuel Weiss; Patrick T Gunning Journal: ACS Med Chem Lett Date: 2013-09-08 Impact factor: 4.345
Authors: Murali K Urlam; Roberta Pireddu; Yiyu Ge; Xiaolei Zhang; Ying Sun; Harshani R Lawrence; Wayne C Guida; Saïd M Sebti; Nicholas J Lawrence Journal: Medchemcomm Date: 2013-06 Impact factor: 3.597
Authors: Brent D G Page; Steven Fletcher; Peibin Yue; Zhihua Li; Xiaolei Zhang; Sumaiya Sharmeen; Alessandro Datti; Jeffrey L Wrana; Suzanne Trudel; Aaron D Schimmer; James Turkson; Patrick T Gunning Journal: Bioorg Med Chem Lett Date: 2011-06-30 Impact factor: 2.823
Authors: Anna M Eiring; Brent D G Page; Ira L Kraft; Thomas O'Hare; Patrick T Gunning; Michael W Deininger; Clinton C Mason; Nadeem A Vellore; Diana Resetca; Matthew S Zabriskie; Tian Y Zhang; Jamshid S Khorashad; Alexander J Engar; Kimberly R Reynolds; David J Anderson; Anna Senina; Anthony D Pomicter; Carolynn C Arpin; Shazia Ahmad; William L Heaton; Srinivas K Tantravahi; Aleksandra Todic; Richard Moriggl; Derek J Wilson; Riccardo Baron Journal: Leukemia Date: 2014-08-19 Impact factor: 11.528